Feature | May 20, 2013

Endovascular Repair Of Ruptured Aneurysms Saves More Lives Than Surgery

Ten-year study looks at 106 patients with abdominal aortic aneurysms.

May 20, 2013 — Patients with ruptured abdominal aortic aneurysms (AAA) are more than twice as likely to survive if they have minimally invasive repair than if they have surgery, suggests a 10-year study being.

The aorta is the body’s main artery and about 90 percent of people who suffer from ruptured AAAs bleed to death. Those who make it to the hospital undergo either open surgical repair or minimally invasive treatment with endovascular aneurysm repair (EVAR). 

“Many of these patients are frail, with a variety of health issues, and a minimally invasive solution is by far the best option,” said Sherif Sultan, M.B., M.D., an endovascular surgeon at the University College Hospital Galway, Ireland. “We found 85 percent of patients are suitable for minimally invasive aneurysm repair and in those patients, EVAR should always be the first option.”

The study involved 106 patients who had AAA repair between 2002 and 2012, 75 of whom had open surgery and 31 of whom had EVAR. Overall mortality was higher for surgery patients, with 49 (65 percent) dying within 30 days versus 10 (32 percent) of those who had EVAR. After one year, 12.5 percent of surgery patients were alive versus 56 percent of EVAR patients. Most of the patients died of a co-existing health condition.

AAA is a weakening and ballooning in the aorta, the artery that carries blood from the heart to the rest of the body. AAA is most common in men 65 years or older. Other risk factors include a history of smoking, high blood pressure, high cholesterol and atherosclerosis. The larger the AAA, the more likely it is to rupture. 

Open surgical repair of the aorta involves making a 12-inch incision in the chest and cracking open the ribs to access the aorta. The patient is placed on partial heart-lung bypass, the aorta is clamped off and a fabric graft sewn into place.

EVAR involves threading a collapsed fabric tube, or endograft, through a catheter into a small incision in the groin artery and advancing it through the artery to the site of the tear in the aorta. The endograft is expanded in place, and blood flow is redirected through it, sealing off the tear.

For more information: www.iset.org

Related Content

News | Heart Failure| October 02, 2015
Cyberonics Inc. announced results from the extension of the ANTHEM-HF clinical study (ENCORE Study). Results of the...
Tryton Side Branch Stent, clinical trial results, Catheterization and Cardiovascular Interventions

Tryton Side Branch Stent image courtesy of Tryton Medical

News | Stents Bifurcation| October 02, 2015
October 2, 2015 — Tryton Medical Inc.
Intact Vascular, TOBA II study, Tack Endovascular System

Image courtesy of Intact Vascular

News | Peripheral Arterial Disease (PAD)| October 01, 2015
Intact Vascular Inc. announced the U.S. Food and Drug Administration has granted conditional approval for a U.S. and...
Johns Hopkins, sticky gel, stem cells, rat hearts, heart attacks

Hydrogel applied to beating rat hearts improves stem cell uptake by the heart muscle and speeds up tissue healing after heart attack. Image courtesy of Johns Hopkins Medicine.

News | Stem Cell Therapies| September 29, 2015
A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and...
News | Cath Lab| September 29, 2015
The Innovation Institute announced that Boston Scientific has signed an agreement to become the founding medical device...
Eluvia drug-eluting vascular stent system, 12-month primary patency, Boston Scientific, MAJESTIC trial, CIRSE

Image courtesy of Boston Scientific

News | Stents Peripheral| September 28, 2015
New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific Eluvia drug-eluting...
predicting arrhythmias, mcgill university, alternans patterns
News | EP Lab| September 28, 2015
Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It’s a...
News | Antiplatelet and Anticoagulation Therapies| September 25, 2015
The Icahn School of Medicine at Mount Sinai has launched the international TWILIGHT clinical trial to test the safety...
Medisafe, medication management, mHealth platform, blood pressure study, hypertension, adherence
News | Hypertension| September 25, 2015
Medisafe, an mHealth platform for medication management, announced the results of its blood pressure study, which...
Biotronik, NORDIC ICD trial, defibrillation testing, DF testing, shock efficacy
News | Implantable Cardioverter Defibrillators (ICD)| September 24, 2015
Biotronik announced the publication of NORDIC ICD (NO Regular Defibrillation testing In Cardioverter-Defibrillator...
Overlay Init